{
 "as_of": "2026-11-08",
 "cmr": "us-cm-kg/NASDAQ/DFTX",
 "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.",
 "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# Definium Therapeutics, Inc. (NASDAQ: DFTX) — research page\n\nAs of 2026-11-08 · us-cm-kg · record version 1\n\n## Identity and listing\n\nThe issuer is Definium Therapeutics, Inc., listed on NASDAQ under ticker DFTX, with ISIN US24477V1052. The LEI is not on the record, as no GLEIF record carries the exact legal name in jurisdiction US-A1. The security type is Corporate, the segment is not on the record, the sector is 2833 Medicinal Chemicals & Botanical Products, and the jurisdiction is British Columbia, Canada. The issuer is listed and not halted.\n\n## The disclosure read\n\nThe record holds 95 filings in the window from 2025-11-08 to 2026-11-08, across 34 filing days. The median gap between filing days is 6 days. The latest filing is dated 2026-11-05, 3 days before the record date of 2026-11-08, and its type is regulatory_filing. The NASDAQ median gap between filing days is 6.0 days, and the issuer's gap is equal to it. The NASDAQ median filings in the window is 52, and the issuer's count is below it. The NASDAQ median latency is 5.0 days, and the issuer's latency is below it. The sector median gap between filing days is 7.2 days, and the issuer's gap is below it. The sector median filings in the window is 40.0, and the issuer's count is above it. The sector median latency is 4.5 days, and the issuer's latency is below it. By type, the window holds 47 directors_dealings, 27 regulatory_filing, 8 corporate_news, 7 results, 2 agm_egm, 2 director_change and 2 prospectus filings.\n\n## Auditor\n\nThe auditor is not on the record, as the latest annual report cover carries no dei:AuditorName tag. The auditor's location is not on the record. The record holds no auditor changes.\n\n## Events and halts\n\nThe record holds no listing, delisting or name change lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted.\n\n## Orderability\n\nThe outcome is not determinable under rule version acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, as the chapter's orderability section carries no client_categories and so the outcome cannot name its client category. The chapter is as of 2026-11-04.\n\n## Coverage\n\nThe record finds no research houses named on the issuer's investor-relations page, and the count is 0.\n\n## Open research\n\nThe record finds no openly published research notes for the issuer.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe record holds sealed years 2021, 2022, 2023, 2024, 2025 and 2026 for the issuer. The market's earliest sealed date is 2021-01-04, and the live record began on 2026-09-12.\n\n## Sources\n\n7 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)\n- https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin)\n- https://data.sec.gov/submissions/CIK0001813814.json (identity.jurisdiction)\n- https://mcp.us-cm-kg.ai/events/NASDAQ/DFTX (the disclosure lines)\n- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)\n- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://mcp.us-cm-kg.ai/record/NASDAQ/DFTX (the record)\n",
 "market": "US",
 "node": "us-cm-kg",
 "numbers": {
  "as_of_depth": {
   "issuer_years_sealed": [
    "2021",
    "2022",
    "2023",
    "2024",
    "2025",
    "2026"
   ],
   "live_record_began": "2026-09-12",
   "node_history_from": "2021-01-04",
   "node_years_sealed": [
    "2021",
    "2022",
    "2023",
    "2024",
    "2025",
    "2026"
   ],
   "record_version": 1,
   "sealed": true
  },
  "auditor": {
   "auditor": {
    "market": "US",
    "reason": "no dei:AuditorName tag on the latest annual report cover (foreign private issuers and older filings carry none)",
    "state": "not_on_record"
   },
   "auditor_firm_id": {
    "market": "US",
    "state": "not_on_record"
   },
   "auditor_location": {
    "market": "US",
    "state": "not_on_record"
   },
   "changes": []
  },
  "cmr": "us-cm-kg/NASDAQ/DFTX",
  "coverage": {
   "count": 0,
   "houses": [],
   "pages_checked": [
    {
     "page": "https://ir.definiumtx.com/analyst-coverage",
     "result": "not the issuer's own investor-relations page — not read"
    }
   ],
   "read_by": "Perplexity sonar (search) · page read by this rail",
   "read_date": "2026-11-11",
   "since": null,
   "state": "none_found"
  },
  "disclosure": {
   "against": {
    "exchange": {
     "issuers": 4359,
     "median_cadence_gap_days": 6,
     "median_filings": 52,
     "median_latency_days": 5,
     "name": "NASDAQ"
    },
    "sector": {
     "issuers": 18,
     "median_cadence_gap_days": 7.2,
     "median_filings": 40,
     "median_latency_days": 4.5,
     "name": "2833 Medicinal Chemicals & Botanical Products"
    }
   },
   "by_type": {
    "agm_egm": 2,
    "corporate_news": 8,
    "director_change": 2,
    "directors_dealings": 47,
    "prospectus": 2,
    "regulatory_filing": 27,
    "results": 7
   },
   "cadence_median_gap_days": 6,
   "filing_days": 34,
   "filings": 95,
   "latency_days": 3,
   "latest": [
    {
     "category": "SCHEDULE 13G",
     "date": "2026-11-05",
     "source": "https://www.sec.gov/Archives/edgar/data/1813814/000031506626002739/xslSCHEDULE_13G_X02/primary_doc.xml",
     "title": "SCHEDULE 13G",
     "type": "regulatory_filing"
    },
    {
     "category": "4",
     "date": "2026-09-29",
     "source": "https://www.sec.gov/Archives/edgar/data/1813814/000110465926112065/xslF345X06/tm2626627-5_4seq1.xml",
     "title": "4 — OWNERSHIP DOCUMENT",
     "type": "directors_dealings"
    },
    {
     "category": "4",
     "date": "2026-09-29",
     "source": "https://www.sec.gov/Archives/edgar/data/1813814/000110465926112062/xslF345X06/tm2626627-4_4seq1.xml",
     "title": "4 — OWNERSHIP DOCUMENT",
     "type": "directors_dealings"
    },
    {
     "category": "4",
     "date": "2026-09-29",
     "source": "https://www.sec.gov/Archives/edgar/data/1813814/000110465926112061/xslF345X06/tm2626627-3_4seq1.xml",
     "title": "4 — OWNERSHIP DOCUMENT",
     "type": "directors_dealings"
    },
    {
     "category": "4",
     "date": "2026-09-29",
     "source": "https://www.sec.gov/Archives/edgar/data/1813814/000110465926112060/xslF345X06/tm2626627-2_4seq1.xml",
     "title": "4 — OWNERSHIP DOCUMENT",
     "type": "directors_dealings"
    }
   ],
   "latest_filing_date": "2026-11-05",
   "read": "the node's event lines (list_events_since), as get_filings serves them",
   "source": "https://mcp.us-cm-kg.ai/events/NASDAQ/DFTX",
   "window": {
    "from": "2025-11-08",
    "to": "2026-11-08"
   }
  },
  "identity": {
   "exchange": {
    "read_by": "EDGAR company_tickers_exchange.json (SEC list of exchange-listed filers)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/files/company_tickers_exchange.json",
    "state": "sourced",
    "value": "NASDAQ"
   },
   "isin": {
    "read_by": "SEC Fails-to-Deliver data (CUSIP for the symbol) · ISIN = US + CUSIP + ISO 6166 check digit",
    "read_date": "2026-10-14",
    "read_date_basis": "last_seen",
    "source": "https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data",
    "state": "sourced",
    "value": "US24477V1052"
   },
   "jurisdiction": {
    "read_by": "EDGAR submissions API (issuer header as filed) (stateOfIncorporation)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001813814.json",
    "state": "sourced",
    "value": "British Columbia, Canada"
   },
   "lei": {
    "market": "US",
    "reason": "no GLEIF record with the exact legal name in jurisdiction US-A1",
    "state": "not_on_record"
   },
   "name": {
    "read_by": "EDGAR submissions API (issuer header as filed)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001813814.json",
    "state": "sourced",
    "value": "Definium Therapeutics, Inc."
   },
   "sector": {
    "read_by": "EDGAR submissions API (issuer header as filed) (SIC code as assigned by the SEC)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001813814.json",
    "state": "sourced",
    "value": "2833 Medicinal Chemicals & Botanical Products"
   },
   "security_type": {
    "read_by": "EDGAR submissions API (issuer header as filed)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001813814.json",
    "state": "sourced",
    "value": "Corporate"
   },
   "segment": {
    "market": "US",
    "state": "not_on_record"
   },
   "ticker": {
    "read_by": "EDGAR company_tickers_exchange.json (SEC list of exchange-listed filers)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/files/company_tickers_exchange.json",
    "state": "sourced",
    "value": "DFTX"
   },
   "website": {
    "market": "US",
    "state": "not_on_record"
   }
  },
  "licensed": {
   "columns": [
    "licensor",
    "entitlement",
    "title",
    "date",
    "source"
   ],
   "rows": [],
   "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded."
  },
  "lifecycle": {
   "delisting": [],
   "domicile_change": {
    "market": "US",
    "reason": "EDGAR states no dated change of state of incorporation on a filing line",
    "state": "not_on_record"
   },
   "listing": [],
   "name_change": [],
   "segment_move": {
    "market": "US",
    "reason": "the exchanges' tier transfers are not EDGAR filings",
    "state": "not_on_record"
   }
  },
  "market": "US",
  "node": "us-cm-kg",
  "numbers_hash": "sha256:159599bb29c06a248cf4eea6cd5381bc2d6b13444dcd139fdbd03d4923ef42f8",
  "open_research": {
   "read_date": "2026-11-11",
   "rows": [],
   "state": "none_found"
  },
  "orderability": {
   "chapter_as_of": "2026-11-04",
   "client_categories": [],
   "determinable": false,
   "read": {
    "chapter": "https://mcp.us-cm-kg.ai/book/aio.json",
    "door": "https://mcp.us-cm-kg.ai/mcp",
    "tool": "get_orderability"
   },
   "reason": "the chapter's orderability section carries no client_categories: the outcome cannot name its client category",
   "rule_version": "acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1",
   "section": "us.aio.v8"
  },
  "record": {
   "as_of": "2026-11-08",
   "url": "https://mcp.us-cm-kg.ai/record/NASDAQ/DFTX",
   "version": 1
  },
  "schema": "research-numbers v0.1 (USR-01, 2026-11-11)",
  "status": {
   "read_date": "2026-11-08",
   "source": "https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts",
   "value": "listed, not halted"
  }
 },
 "numbers_hash": "sha256:159599bb29c06a248cf4eea6cd5381bc2d6b13444dcd139fdbd03d4923ef42f8",
 "path": "/us/NASDAQ/DFTX",
 "schema": "research-page v0.1 (USR-02, 2026-11-11)",
 "sections": [
  {
   "id": "identity",
   "text": "The issuer is Definium Therapeutics, Inc., listed on NASDAQ under ticker DFTX, with ISIN US24477V1052. The LEI is not on the record, as no GLEIF record carries the exact legal name in jurisdiction US-A1. The security type is Corporate, the segment is not on the record, the sector is 2833 Medicinal Chemicals & Botanical Products, and the jurisdiction is British Columbia, Canada. The issuer is listed and not halted.",
   "title": "Identity and listing"
  },
  {
   "id": "disclosure",
   "text": "The record holds 95 filings in the window from 2025-11-08 to 2026-11-08, across 34 filing days. The median gap between filing days is 6 days. The latest filing is dated 2026-11-05, 3 days before the record date of 2026-11-08, and its type is regulatory_filing. The NASDAQ median gap between filing days is 6.0 days, and the issuer's gap is equal to it. The NASDAQ median filings in the window is 52, and the issuer's count is below it. The NASDAQ median latency is 5.0 days, and the issuer's latency is below it. The sector median gap between filing days is 7.2 days, and the issuer's gap is below it. The sector median filings in the window is 40.0, and the issuer's count is above it. The sector median latency is 4.5 days, and the issuer's latency is below it. By type, the window holds 47 directors_dealings, 27 regulatory_filing, 8 corporate_news, 7 results, 2 agm_egm, 2 director_change and 2 prospectus filings.",
   "title": "The disclosure read"
  },
  {
   "id": "auditor",
   "text": "The auditor is not on the record, as the latest annual report cover carries no dei:AuditorName tag. The auditor's location is not on the record. The record holds no auditor changes.",
   "title": "Auditor"
  },
  {
   "id": "events",
   "text": "The record holds no listing, delisting or name change lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted.",
   "title": "Events and halts"
  },
  {
   "id": "orderability",
   "text": "The outcome is not determinable under rule version acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, as the chapter's orderability section carries no client_categories and so the outcome cannot name its client category. The chapter is as of 2026-11-04.",
   "title": "Orderability"
  },
  {
   "id": "coverage",
   "text": "The record finds no research houses named on the issuer's investor-relations page, and the count is 0.",
   "title": "Coverage"
  },
  {
   "id": "open_research",
   "text": "The record finds no openly published research notes for the issuer.",
   "title": "Open research"
  },
  {
   "id": "licensed",
   "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.",
   "title": "Licensed"
  },
  {
   "id": "depth",
   "text": "The record holds sealed years 2021, 2022, 2023, 2024, 2025 and 2026 for the issuer. The market's earliest sealed date is 2021-01-04, and the live record began on 2026-09-12.",
   "title": "As-of depth"
  },
  {
   "id": "sources",
   "text": "7 source pages are named on this page; every value above carries its own source page and read date in the numbers.",
   "title": "Sources"
  }
 ],
 "sources": [
  {
   "for": "identity.exchange",
   "source": "https://www.sec.gov/files/company_tickers_exchange.json"
  },
  {
   "for": "identity.isin",
   "source": "https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data"
  },
  {
   "for": "identity.jurisdiction",
   "source": "https://data.sec.gov/submissions/CIK0001813814.json"
  },
  {
   "for": "the disclosure lines",
   "source": "https://mcp.us-cm-kg.ai/events/NASDAQ/DFTX"
  },
  {
   "for": "the halt flag",
   "source": "https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts"
  },
  {
   "for": "the orderability chapter",
   "source": "https://mcp.us-cm-kg.ai/book/aio.json"
  },
  {
   "for": "the record",
   "source": "https://mcp.us-cm-kg.ai/record/NASDAQ/DFTX"
  }
 ],
 "title": "Definium Therapeutics, Inc. (DFTX) — research page",
 "writer": {
  "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers",
  "engine": "claude-haiku-5-5"
 }
}